mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.04 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.05 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |